• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

REMEGEN(09995.HK)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Dec18
Rongchang Bio Receives a RMB 36 Million Loan Commitment from China Merchants Bank
12:40
Dec15
Rongchang Biotechnology Plans to Repurchase A-shares for Up to 40 Million Yuan
16:32
Nov28
BlackRock cuts holdings in RemeGen by 185,500 shares
12:15
Nov26
East China Securities Issues Buy Rating for Rongchang Biotechnology
07:34
Nov18
CFC 上调荣昌生物目标价及盈利预测
01:17
Nov11
Rongchang Biotech Reports Strong Revenue Growth but Persistent Losses in Q3 2025
09:57

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 679.82 M, Net Income -110.55 M, EPS -0.2001

Aug22
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 626.05 M, Net Income -213.9 M, EPS -0.4029

Apr28
Earning Release(CST)

FY2025 Q1 Earning Release (HKD) Revenue 563.3 M, Net Income -272.18 M, EPS -0.4926

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
00312
0.081
+68.75%
+0.033
01271
1.270
+45.98%
+0.400
00191
0.720
+44.00%
+0.220
01725
1.000
+42.86%
+0.300
01045
3.740
+34.53%
+0.960
08460
3.000
+32.74%
+0.740
00498
0.155
+29.17%
+0.035
02478
1.620
+26.56%
+0.340
08429
0.070
+25.00%
+0.014
08311
0.098
+24.05%
+0.019
View More